Latest Quarterly Financial Results News

333D Limited reported a 12% increase in quarterly cash receipts from digital asset management contracts, maintaining steady cash flow despite slight operating cash usage. The company’s annual contract revenue surpassed $970,000, reflecting growing traction in healthcare digital services.

FINEOS Corporation Holdings PLC reports steady revenue growth and operational efficiencies in Q2 2025, alongside new client contracts in North America that bolster its outlook for positive free cash flow this fiscal year.

Australian Dairy Nutritionals Limited has reported a record-breaking quarter with total revenue soaring 119% year-on-year, driven by an 801% jump in nutritional powder sales and expanded distribution in China.

Epx Limited reports sustained operational improvement with four consecutive quarters of positive cash inflows and a 26% increase in customer receipts for the June 2025 quarter.

Metro Mining Limited has reported record Q2 shipments and site EBITDA margins, driven by a fully operational expansion and a robust bauxite market. Operational challenges from a tropical storm have been resolved, and exploration activities are accelerating.

International Equities Corporation Ltd has revealed a significant revenue drop and net loss for Q2 2025, citing economic slowdown and weak tourism as key challenges. The company signals cautious optimism for the hospitality sector despite ongoing cost pressures.

Phoslock Environmental Technologies reported a $474,000 cashflow deficit in Q2 2025, with sales impacted by deferred European projects and ongoing US tariff uncertainties. Factory refurbishment delays push production restart to early 2026.

Black Cat Syndicate reported a 33% jump in gold production for the June quarter, driven by ramped-up operations and strategic acquisitions, with even stronger growth forecast for September despite scheduled maintenance.

New Hope Corporation reports steady coal production but a 27% drop in EBITDA amid falling prices and rail constraints, prompting revised FY25 guidance.

Universal Biosensors reported a 6% increase in revenue for Q1 2025 but posted a net loss of A$3.84 million, with cash reserves sufficient only through Q3 2025, raising questions about its financial sustainability.

PEXA Group’s third-quarter results align with expectations, driven by Australian growth and UK market headwinds. The company reaffirms its FY25 guidance while navigating ongoing business assessments and regulatory milestones.

Anagenics Limited has reported a net profit before tax of $138,000 for the quarter ended March 31, 2025, marking a significant turnaround following recent restructuring efforts. Despite a temporary revenue setback due to a warehousing transition, the company’s operating cash flow improved markedly.